用五种迄今未经测试的香料进行贴片测试的结果:在临床人群中进行剂量确定研究
Thanisorn Sukakul1, Wolfgang Uter2, Margarida Gonçalo3
1Department of Occupational and Environmental Dermatology, Faculty of Medicine, Lund University, Malmö, Sweden.
Contact dermatitis
|February 22, 2024
概括
香水成分的定量风险评估 (QRA) 对产品安全至关重要. 这项研究在373名患者中没有发现过敏反应,他们用5种新型香料进行了补丁测试,这表明安全使用水平.
科学领域:
- 皮肤病学 皮肤病学
- 毒理学 毒理学 毒理学
- 化品科学 化品科学
背景情况:
- 定量风险评估 (QRA) 确定了在消费品中使香水成分敏感的安全使用水平.
- 对接触性过敏患病率的营销后监测会告知这些安全措施的有效性.
研究的目的:
- 为五种以前没有定期测试过的香料确定适当的补丁试验度.
- 将这些度用于一项监测研究,该研究涉及长期连续患者的贴片测试.
主要方法:
- 在四个诊所进行了补丁测试,对五种香水材料 (法拉,跨-2-六甲,4,8-二甲-4,9-十甲,长叶,甲) 进行了补丁测试.
- 测试涉及三轮,度升级,对过敏和刺激反应的监测.
主要成果:
- 共有373名患者参加了贴片测试.
- 对测试的五种香料成分没有观察到任何积极的过敏反应.
- 其他香水过敏原的结果也被记录在案.
结论:
- 使用的最高度被认为是患者常规贴片检测的安全标准.
- 未来的监测将评估QRA衍生的消费产品水平是否可以防止香味敏感性.
相关概念视频
Patch Clamp
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...


